Xenon Pharmaceuticals Inc. — Director's Dealing 2021

Jun 4, 2021

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Xenon Pharmaceuticals Inc. (XENE)
CIK: 0001582313
Period of Report: 2021-06-03

Reporting Person: GAROFALO ELIZABETH A. (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
No securities are beneficially owned.	0	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
No securities are beneficially owned.	$0.00		N/A ()		Direct

Footnotes

F1: Not applicable.